- 同花顺特色产品
- 〈高级诊股〉 全方位深度分析，提供明确投资建议
- 短期趋势：
强势上涨过程中，可逢低买进，暂不考虑做空。
- 中期趋势：
-
- 长期趋势：
已有162家主力机构披露2024-12-31报告期持股数据，持仓量总计1.05亿股，占流通A股20.86%
- 波段诊断：
-
技术面诊股
诊断结果：3.0技术面打败了26%的股票
技术面评分前10的股票
近期的平均成本为15.00元。
平均成本
近期的平均成本为15.00元。
[{"text":"\u5e73\u5747\u6210\u672c","value":"15.00","date":1751272040,"color":"0x9f0ba1"}]
市场表现
过去10个交易日，该股走势接近大盘，接近行业平均水平。
[{"date":"2025.07.01","stock":"0.54","trade":"1.25","ind":"0.11"},{"date":"2025.06.30","stock":"-0.13","trade":"3.53","ind":"0.83"},{"date":"2025.06.27","stock":"3.25","trade":"1.43","ind":"0.34"},{"date":"2025.06.26","stock":"-0.76","trade":"-1.05","ind":"-0.48"},{"date":"2025.06.25","stock":"2.82","trade":"0.45","ind":"1.72"},{"date":"2025.06.24","stock":"1.65","trade":"1.52","ind":"1.68"},{"date":"2025.06.23","stock":"2.50","trade":"1.79","ind":"0.43"},{"date":"2025.06.20","stock":"-1.59","trade":"-0.53","ind":"-0.47"},{"date":"2025.06.19","stock":"-2.75","trade":"-2.20","ind":"-1.21"},{"date":"2025.06.18","stock":"-1.93","trade":"-2.14","ind":"0.24"},{"date":"2025.06.17","stock":"-0.61","trade":"-0.60","ind":"-0.12"},{"date":"2025.06.16","stock":"-1.99","trade":"0.70","ind":"0.41"},{"date":"2025.06.13","stock":"1.48","trade":"-3.10","ind":"-1.10"},{"date":"2025.06.12","stock":"0.40","trade":"1.18","ind":"-0.11"},{"date":"2025.06.11","stock":"-1.07","trade":"-0.62","ind":"0.83"},{"date":"2025.06.10","stock":"-2.09","trade":"0.33","ind":"-0.86"},{"date":"2025.06.09","stock":"2.48","trade":"3.36","ind":"0.65"},{"date":"2025.06.06","stock":"-2.48","trade":"-0.86","ind":"-0.19"},{"date":"2025.06.05","stock":"2.34","trade":"-1.15","ind":"0.58"},{"date":"2025.06.04","stock":"1.56","trade":"0.74","ind":"0.87"},{"date":"2025.06.03","stock":"3.22","trade":"2.72","ind":"0.16"}]
迪安诊断,深证成指,医疗服务指数
压力支撑
该股压力位为14.96元，支撑位为14.69元。
[{"text":"\u538b\u529b\u4f4d","value":"14.96","date":1751299200,"color":"0x9f0ba1"},{"text":"\u652f\u6491\u4f4d","value":"14.69","date":1751299200,"color":"0x0b52a1"}]
多空趋势
macd
kdj
boll
asi
bias
rsi
wr
vr
资金面诊股
诊断结果：3.8资金面打败了48%的股票
主力控盘前10的股票
行业资金
医疗服务行业， 近5日资金总体无进出。
更新时间：07月01日 20:34
| 机构今日流向(万元) | -242.64 | 机构5日流向(万元) | 730.64 |
| 机构10日流向(万元) | -5832.55 | 机构20日流向(万元) | -21793.18 |
机构持仓
2024-12-31 与 2024-06-30 相比，主力机构持仓量减少2059.57万股，其中基金净减仓2家，主力净增仓8家，暂未发现中长期投资价值。
截止2024-12-31，共162家主力机构（基金157家，一般法人2家，QFII3家），持仓量总计10461.12万股，占流通A股20.86%
其中，基金持仓与2024-06-30相比：
增仓：35家 ，增持 431.49万股
减仓：37家 ，减持 465.26万股
新出现在主力名单中：75家 ，持有1659.65万股
从主力名单中消失：67家 ，原持有3225.97万股
其中，基金持仓与2024-06-30相比：
增仓：35家 ，增持 431.49万股
减仓：37家 ，减持 465.26万股
新出现在主力名单中：75家 ，持有1659.65万股
从主力名单中消失：67家 ，原持有3225.97万股
消息面诊股
诊断结果：5.6消息面打败了28%的股票
今日有利好新闻的公司
近期该股消息面总体多空平衡，没有较强的利好或利空趋势。
更多>>个股资讯
- 迪安诊断：6月30日获融资买入3934.74万元
2025-07-01 - 迪安诊断：6月27日获融资买入4665.46万元，
2025-06-30 - 迪安诊断：医疗AI业务尚处于投入阶段
2025-06-28 - 双重历史底部，4年暴跌近80%，中东土豪都开始抢筹
2025-06-27 - 迪安诊断：公司依托自研的“启迪索微”大模型，已正式
2025-06-27 - 迪安诊断：预计未来三年AI业务收入将远超100%的
2025-06-27 - 迪安诊断：公司于2024年通过集中竞价方式累计回购
2025-06-27 - 行业周报|医疗服务指数涨4.19%, 跑赢上证指数
2025-06-27 - 迪安诊断：公司在胎儿和婴幼儿诊断领域已形成较为全面
2025-06-27 - 迪安诊断：常规业务应收款处于正常回款滚动周期
2025-06-27
消息列表
| 一般消息 | 重大事项 | 公司股东股份解押 | 2025-06-27 |
| 一般消息 | 重大事项 | 关联交易 | 2025-05-30 |
| 一般消息 | 股东大会 | 年度股东大会 | 2025-04-23 |
| 利好 | 分红转增 | 10派2.5元(含税) | 2025-04-23 |
| 一般消息 | 重大事项 | 关联交易 | 2025-04-23 |
| 利空 | 业绩预告 | 业绩预亏 | 2025-01-24 |
| 一般消息 | 重大事项 | 公司股东股份解押 | 2025-01-02 |
| 一般消息 | 重大事项 | 关联交易 | 2024-09-27 |
| 一般消息 | 重大事项 | 公司股东股份解押 | 2024-09-23 |
| 利好 | 分红转增 | 10派6.5元(含税) | 2024-08-24 |
| 一般消息 | 重大事项 | 公司股东股份解押 | 2024-08-15 |
一年消息统计
| 所有消息 | 重大消息 | 非重大消息 | |
| 利好 | 2条 | 0条 | 2条 |
| 利空 | 1条 | 0条 | 1条 |
行业面诊股
诊断结果：7.0行业面打败了89%的股票
医疗服务行业最新资金流向
近10日来该行业走势不明显，接近大盘。最近120个交易日，机构评级以增持为主，认为该行业有一定投资价值。
行业走势
近10日来该行业走势不明显，接近大盘。
[{"date":"2025.07.01","price":"0.11","value":"1.25"},{"date":"2025.06.30","price":"0.83","value":"3.53"},{"date":"2025.06.27","price":"0.34","value":"1.43"},{"date":"2025.06.26","price":"-0.48","value":"-1.05"},{"date":"2025.06.25","price":"1.72","value":"0.45"},{"date":"2025.06.24","price":"1.68","value":"1.52"},{"date":"2025.06.23","price":"0.43","value":"1.79"},{"date":"2025.06.20","price":"-0.47","value":"-0.53"},{"date":"2025.06.19","price":"-1.21","value":"-2.20"},{"date":"2025.06.18","price":"0.24","value":"-2.14"},{"date":"2025.06.17","price":"-0.12","value":"-0.60"},{"date":"2025.06.16","price":"0.41","value":"0.70"},{"date":"2025.06.13","price":"-1.10","value":"-3.10"},{"date":"2025.06.12","price":"-0.11","value":"1.18"},{"date":"2025.06.11","price":"0.83","value":"-0.62"},{"date":"2025.06.10","price":"-0.86","value":"0.33"},{"date":"2025.06.09","price":"0.65","value":"3.36"},{"date":"2025.06.06","price":"-0.19","value":"-0.86"},{"date":"2025.06.05","price":"0.58","value":"-1.15"},{"date":"2025.06.04","price":"0.87","value":"0.74"},{"date":"2025.06.03","price":"0.16","value":"2.72"}]
深证成指,医疗服务行业
行业排名
| 排名 | 股票名称 | 1月涨跌幅 | 5日涨跌幅 | 评分 |
|---|---|---|---|---|
| 1 | *ST生物 | 36.03% | 6.82% | 4.3分 |
| 2 | 毕得医药 | 31.04% | 15.29% | 6.2分 |
| 3 | 创新医疗 | 26.66% | 21.08% | 4.9分 |
| 4 | 南模生物 | 22.93% | 17.37% | 5.7分 |
| 5 | 昭衍新药 | 16.82% | 15.84% | 5.3分 |
| 6 | 药康生物 | 16.19% | 17.64% | 5.9分 |
| 8 | 皓元医药 | 10.62% | 10.87% | 5.7分 |
| 10 | 泰格医药 | 9.12% | 6.25% | 5.4分 |
| 12 | 博腾股份 | 5.94% | 6.08% | 5.0分 |
| 14 | 盈康生命 | 4.99% | 4.44% | 5.0分 |
| 16 | 万邦医药 | 4.62% | 3.49% | 3.9分 |
| 18 | 澳洋健康 | 4.21% | 2.86% | 4.1分 |
| 20 | 迪安诊断 | 3.38% | 5.79% | 4.5分 |
| 22 | 皓宸医疗 | 3.18% | -1.68% | 4.4分 |
| 24 | 美迪西 | 2.95% | 2.74% | 5.2分 |
| 26 | 泓博医药 | 2.72% | 8.75% | 5.3分 |
| 28 | 九洲药业 | 1.73% | 5.39% | 5.7分 |
| 30 | 华康洁净 | 0.21% | 2.24% | 4.9分 |
| 32 | 爱尔眼科 | -0.48% | 0.65% | 4.9分 |
| 34 | 美年健康 | -0.76% | 3.80% | 5.2分 |
| 36 | 普蕊斯 | -1.60% | 5.96% | 4.3分 |
| 38 | 睿智医药 | -1.89% | 6.34% | 4.7分 |
| 40 | 普瑞眼科 | -3.39% | 3.20% | 4.9分 |
| 42 | 金域医学 | -3.49% | 1.46% | 4.7分 |
| 44 | 华大基因 | -4.00% | 0.79% | 3.9分 |
| 46 | 新里程 | -5.11% | -1.33% | 4.1分 |
| 48 | 百花医药 | -7.66% | 0.96% | 4.6分 |
| 50 | 阳光诺和 | -8.52% | 11.74% | 5.9分 |
| 52 | - | - | 153.01% | 分 |
行业评级
最近120个交易日，机构评级以增持为主，认为该行业有一定投资价值。
- 综合评级
| 研究机构 | 评级日期 | 最新评级 | 上次评级 |
| 安信证券 | 2012-09-04 | 增持 | 增持 |
| 长江证券 | 2012-09-02 | 增持 | - |
更多>>行业资讯
- 2012-09-13北京药监局通知全市停用8家企业中药饮片
- 2012-09-13澳洲股指周四收跌0.5% 医疗及消费股领跌
- 2012-09-13基层中医药服务能力将获提升
- 2012-09-132012中国医疗卫生产业发展论坛召开
- 2012-09-13医药行业：媒体称新版基药目录品种将扩至700个
- 2012-09-13陕西县级公立医院改革全面推开
- 2012-09-138月中山CPI 环比涨0.1%
- 2012-09-13中金公司：医药板块选股坚持“稳健业绩+成长空间预期
- 2012-09-13澳洲股指周四盘初跌0.5% 医疗及消费股领跌
- 2012-09-13感冒药“实名制”个人信息易“走光”？ 法国立法严管
基本面诊股
[ 截止日期：2025-03-31 ]公司经营
盈利能力：一般，低于行业平均，建议投资者谨慎，两项指标的行业排名分别为 37/100 ， 40/100。
[{"date":"2025-03-31","value":"-0.32","vol":"0.92"},{"date":"2024-12-31","value":"-5.06","vol":"-0.15"},{"date":"2024-09-30","value":"1.79","vol":"3.24"},{"date":"2024-06-30","value":"0.96","vol":"2.52"},{"date":"2024-03-31","value":"0.31","vol":"1.10"}]
| 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | |
|---|---|---|---|---|---|
| 净资产收 益率(%) |
-0.32 | -5.06 | 1.79 | 0.96 | 0.31 |
| 行业(%) | 0.92 | -0.15 | 3.24 | 2.52 | 1.10 |
该指标值越高，盈利能力越强，行业排名越靠前。
[{"date":"2025-03-31","value":"26.39","vol":"34.67"},{"date":"2024-12-31","value":"28.01","vol":"34.77"},{"date":"2024-09-30","value":"28.05","vol":"36.16"},{"date":"2024-06-30","value":"27.69","vol":"36.37"},{"date":"2024-03-31","value":"25.53","vol":"36.30"}]
| 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | |
|---|---|---|---|---|---|
| 销售毛利 率(%) |
26.39 | 28.01 | 28.05 | 27.69 | 25.53 |
| 行业(%) | 34.67 | 34.77 | 36.16 | 36.37 | 36.30 |
该指标值越高，盈利能力越强，行业排名越靠前。
成长能力：偏弱，与行业平均有较大差距，两项指标的行业排名分别为 46/100 ， 49/100。
[{"date":"2025-03-31","value":"-20.45","vol":"-0.08"},{"date":"2024-12-31","value":"-9.04","vol":"-0.73"},{"date":"2024-09-30","value":"-10.05","vol":"0.87"},{"date":"2024-06-30","value":"-9.12","vol":"0.65"},{"date":"2024-03-31","value":"-8.01","vol":"3.42"}]
| 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | |
|---|---|---|---|---|---|
| 营业收入同 比增长率(%) |
-20.45 | -9.04 | -10.05 | -9.12 | -8.01 |
| 行业(%) | -0.08 | -0.73 | 0.87 | 0.65 | 3.42 |
该指标值越高，成长能力越强，行业排名越靠前。
[{"date":"2025-03-31","value":"-190.66","vol":"-25.93"},{"date":"2024-12-31","value":"-216.20","vol":"-96.53"},{"date":"2024-09-30","value":"-75.35","vol":"-161.08"},{"date":"2024-06-30","value":"-84.17","vol":"-107.95"},{"date":"2024-03-31","value":"-85.54","vol":"-51.89"}]
| 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | |
|---|---|---|---|---|---|
| 净利润同比 增长率(%) |
-190.66 | -216.20 | -75.35 | -84.17 | -85.54 |
| 行业(%) | -25.93 | -96.53 | -161.08 | -107.95 | -51.89 |
该指标值越高，成长能力越强，行业排名越靠前。
营运能力：尚可，接近行业平均，可适当关注，两项指标的行业排名分别为 5/100 ， 28/100。
[{"date":"2025-03-31","value":"0.15","vol":"0.10"},{"date":"2024-12-31","value":"0.72","vol":"0.41"},{"date":"2024-09-30","value":"0.53","vol":"0.31"},{"date":"2024-06-30","value":"0.35","vol":"0.20"},{"date":"2024-03-31","value":"0.17","vol":"0.10"}]
| 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | |
|---|---|---|---|---|---|
| 总资产周 转率(次) |
0.15 | 0.72 | 0.53 | 0.35 | 0.17 |
| 行业(次) | 0.10 | 0.41 | 0.31 | 0.20 | 0.10 |
该指标值越高，营运能力越强，行业排名越靠前。
[{"date":"2025-03-31","value":"1.07","vol":"3.76"},{"date":"2024-12-31","value":"5.59","vol":"16.35"},{"date":"2024-09-30","value":"4.03","vol":"14.25"},{"date":"2024-06-30","value":"2.89","vol":"8.86"},{"date":"2024-03-31","value":"1.44","vol":"4.59"}]
| 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | |
|---|---|---|---|---|---|
| 存货增长 率(次) |
1.07 | 5.59 | 4.03 | 2.89 | 1.44 |
| 行业(次) | 3.76 | 16.35 | 14.25 | 8.86 | 4.59 |
该指标值越高，营运能力越强，行业排名越靠前。
现金流能力：数据暂时不全，请后续关注
[{"date":"2025-03-31","value":"-7.15","vol":"-1.69"},{"date":"2024-12-31","value":"39.25","vol":"22.34"},{"date":"2024-09-30","value":"10.96","vol":"12.23"},{"date":"2024-06-30","value":"-0.37","vol":"9.92"},{"date":"2024-03-31","value":"-8.98","vol":"0.21"}]
| 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | |
|---|---|---|---|---|---|
| 现金流量净额/营业收入 | -7.15 | 39.25 | 10.96 | -0.37 | -8.98 |
| 行业 | -1.69 | 22.34 | 12.23 | 9.92 | 0.21 |
该指标值越高，现金流能力越强，行业排名越靠前。
[{"date":"2025-03-31","value":"","vol":"0.00"},{"date":"2024-12-31","value":"0.50","vol":"1.31"},{"date":"2024-09-30","value":"","vol":"0.00"},{"date":"2024-06-30","value":"0.35","vol":"1.44"},{"date":"2024-03-31","value":"","vol":"0.00"}]
| 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | |
|---|---|---|---|---|---|
| 资本支出／折旧和摊销 | - | 0.50 | - | 0.35 | - |
| 行业 | 0.00 | 1.31 | 0.00 | 1.44 | 0.00 |
该指标值越低，现金流能力越强，行业排名越靠前。
短期偿债能力：很强，位居行业前列,建议强烈关注，两项指标的行业排名分别为 20/100 ， 30/100。
[{"date":"2025-03-31","value":"2.65","vol":"3.84"},{"date":"2024-12-31","value":"2.54","vol":"3.70"},{"date":"2024-09-30","value":"2.61","vol":"4.11"},{"date":"2024-06-30","value":"2.62","vol":"4.14"},{"date":"2024-03-31","value":"2.76","vol":"4.40"}]
| 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | |
|---|---|---|---|---|---|
| 流动比率 |
2.65 | 2.54 | 2.61 | 2.62 | 2.76 |
| 行业 | 3.84 | 3.70 | 4.11 | 4.14 | 4.40 |
该指标值越接近2，短期偿债能力越强，行业排名越靠前。
[{"date":"2025-03-31","value":"2.16","vol":"3.12"},{"date":"2024-12-31","value":"2.08","vol":"3.01"},{"date":"2024-09-30","value":"2.12","vol":"3.38"},{"date":"2024-06-30","value":"2.20","vol":"3.39"},{"date":"2024-03-31","value":"2.33","vol":"3.62"}]
| 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | |
|---|---|---|---|---|---|
| 速动比率 |
2.16 | 2.08 | 2.12 | 2.20 | 2.33 |
| 行业 | 3.12 | 3.01 | 3.38 | 3.39 | 3.62 |
该指标值越接近1，短期偿债能力越强，行业排名越靠前。
长期偿债能力：尚可，接近行业平均，可适当关注，两项指标的行业排名分别为 7/100 ， 11/100。
[{"date":"2025-03-31","value":"42.54","vol":"32.24"},{"date":"2024-12-31","value":"44.46","vol":"32.31"},{"date":"2024-09-30","value":"44.50","vol":"31.03"},{"date":"2024-06-30","value":"43.96","vol":"31.65"},{"date":"2024-03-31","value":"44.50","vol":"31.05"}]
| 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | |
|---|---|---|---|---|---|
| 资产负债 率(%) |
42.54 | 44.46 | 44.50 | 43.96 | 44.50 |
| 行业(%) | 32.24 | 32.31 | 31.03 | 31.65 | 31.05 |
该指标值越接近50%，长期偿债能力越强，行业排名越靠前。
[{"date":"2025-03-31","value":"0.99","vol":"0.98"},{"date":"2024-12-31","value":"1.07","vol":"1.01"},{"date":"2024-09-30","value":"1.08","vol":"0.85"},{"date":"2024-06-30","value":"1.04","vol":"0.87"},{"date":"2024-03-31","value":"1.06","vol":"0.92"}]
| 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | |
|---|---|---|---|---|---|
| 产权比率 (%) |
0.99 | 1.07 | 1.08 | 1.04 | 1.06 |
| 行业(%) | 0.98 | 1.01 | 0.85 | 0.87 | 0.92 |
该指标值越高，长期偿债能力越强，行业排名越靠前。
机构评级
最近60个交易日，机构评级以买入为主，认为该股票非常值得关注。
| 研究机构 | 评级日期 | 最新评级 | 上次评级 |
| 东方证券 | 2025-05-23 | 买入 | |
| 中泰证券 | 2025-05-19 | 买入 | 买入 |
| 太平洋 | 2025-04-29 | 买入 | |
| 中国银河 | 2025-04-23 | 买入 |
机构预测
机构预测该股2025年每股收益与前一年相同，长期投资价值一般。
[{"date":"2021","yellowRectValue":"11.63","blueLineValue":"","type":""},{"date":"2022","yellowRectValue":"14.34","blueLineValue":"","type":""},{"date":"2023","yellowRectValue":"3.07","blueLineValue":"","type":""},{"date":"2024","yellowRectValue":"-3.57","blueLineValue":"","type":""},{"date":"2025","yellowRectValue":"4.48","blueLineValue":"0.72","type":"YC"}]